Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousCombined Modality TherapyGranulocyte Colony-Stimulating FactorAntigens, CD34MelphalanHematologic NeoplasmsStem Cell TransplantationLeukapheresisMultiple MyelomaCyclophosphamideAntineoplastic Combined Chemotherapy ProtocolsBlood Component RemovalGraft SurvivalBone Marrow TransplantationTreatment OutcomeGraft vs Host DiseaseBusulfanMyeloablative AgonistsEtoposideHematopoietic Stem CellsStem CellsLymphoma, Non-HodgkinThiotepaRemission InductionAntineoplastic Agents, AlkylatingRecurrenceCarmustineCytophagocytosisSalvage TherapyIfosfamideAmyloidosisVincristineHematopoiesisHodgkin DiseaseCytarabineRetrospective StudiesDisease-Free SurvivalTissue DonorsCord Blood Stem Cell TransplantationNeoplasmsTransplantation ChimeraSurvival RateWhole-Body IrradiationTime FactorsSurvival AnalysisInfectionHistocompatibilityImmunosuppressive AgentsHistocompatibility TestingLymphoma, T-CellPlatelet CountDoxorubicinCytomegalovirus InfectionsLeukemia, Myeloid, AcutePrednisoneBone Marrow PurgingFollow-Up StudiesCarboplatinPOEMS SyndromeDexamethasoneLeukemiaFatal OutcomeBlood Cell CountAntineoplastic AgentsVidarabineBlood Transfusion, AutologousRecombinant ProteinsProspective StudiesTransplantation, IsogeneicLymphomaFeasibility StudiesGraft vs Leukemia EffectBlood CellsOpportunistic InfectionsEmbryonic Stem CellsAnemia, AplasticImmunophenotypingT-LymphocytesMyelodysplastic SyndromesMesenchymal Stem Cell TransplantationLeukocytes, MononuclearAdult Stem CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveHematologic DiseasesLymphocyte DepletionPrognosisFlow CytometryCell SeparationKidney TransplantationPrecursor Cell Lymphoblastic Leukemia-LymphomaCyclosporineHLA AntigensImmunosuppressionCells, CulturedBreast Neoplasms